NCT00831922View on ClinicalTrials.gov

Efficacy of Oral AB1010 in Adult Patients With Active Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

October 31, 2006

Conditions
Rheumatoid Arthritis
Interventions
DRUG

masitinib (AB1010)

3 mg/kg/day

DRUG

masitinib (AB1010)

6 mg/kg/day

Sponsors

Lead Sponsor

AB Science
All Listed Sponsors
lead

AB Science

INDUSTRY